Japan’s Olympus Corp is close to selling its microscope unit to a private equity firm in a deal that could fetch more than $2.2bn, three people with direct knowledge of the matter told Reuters.
Bain Capital has emerged as the frontrunner, said one of the people and a separate person with direct knowledge of the deal.
Carlyle Group and KKR & Co also submitted binding bids this month for the unit which makes microscopes, industrial endoscopes and x-ray analysers, said three of the people with direct knowledge.
Olympus has been restructuring in recent years with the aim of focusing solely on medical technology and if this sale is successful, it would be the company’s biggest divestment to date, according to Refinitiv data.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
A spokeswoman for Olympus said nothing has been decided at the moment and the company will make announcements when necessary, declining to disclose further details.
Bain, Carlyle and KKR declined to comment. All sources declined to be identified as the information is confidential.
Olympus, which started off as a domestic microscope producer over a century ago, spun off the unit in April, naming it Evident Corp.
Evident had total assets worth 143.3 billion yen by end of March and has forecast operating profit of 15.5 billion yen for the current financial year.
As part of its overhaul, Olympus has invited activist investor ValueAct Capital onto its board, bought several overseas medical-equipment firms and sold its digital camera business that had been a long-time money-loser.
Olympus nearing deal to sell microscope unit for over $2bn, Bain Capital, Carlyle, and KKR are among suitors
Japan’s Olympus Corp is close to selling its microscope unit to a private equity firm in a deal…
Ampersand Capital Partners is pleased to announce the closing of the firm’s latest fund, Ampersand…
Computer Services, a provider of end-to-end fintech solutions, announced that it has entered into…